Fact.MR – A Market Research and Competitive Intelligence Provider: Various invasive medical procedures are susceptible to excessive blood loss, especially cesarean deliveries and major organ surgeries.
Polysaccharide Hemostatic Systems become highly Sought-after as Demand for Minimally Invasive Surgeries Rises
The Fact.MR market survey on the polysaccharide hemostatic testing market provides insights into recent developments across various segments in the market products, applications, and end-users. It also highlights growth strategies adopted by vendors to improve sales in the market
Fact.MR – A Market Research and Competitive Intelligence Provider: Various invasive medical procedures are susceptible to excessive blood loss, especially cesarean deliveries and major organ surgeries. This has highlighted the pressing need for effective blood control management systems.
Owing to this factor, Fact.MR projects positive growth for polysaccharide hemostatic system market during the forecast period 2021-2031.
Due to the growing public awareness regarding minimally invasive medical procedures and pervasiveness of chronic diseases, the demand for polysaccharide hemostatic systems will consistently rise.
These systems effectively control blood loss during surgeries involving sensitive and non-anatomical structures. Patients with hemostatic abnormalities have also been benefitting from these systems, which in turn is boosting applications of polysaccharide hemostatic systems.
Increasing adoption of polysaccharide hemostatic systems among healthcare providers can be attributable to reduction in surgery expenses and quick recovery post-surgical procedures.
Increasing cases of chronic ailments, requiring surgical procedures especially among geriatric population due to high bone density and arthritic disorders is underscoring the need for polysaccharide hemostatic systems in orthopedic surgeries.
As per Fact.MR’s market survey, the U.S. polysaccharide hemostatic system market is anticipated to exhibit positive growth through the report’s assessment period. The increasing adoption of advanced medical technologies in healthcare and rising per capita expenditure in the country are chief growth drivers in the market.
“Increasing cases of surgical procedures will create demand for polysaccharide hemostatic systems in the forthcoming years. Product innovations and technological advancements in the same are anticipated to keep the market afloat amid disruptions caused due to the pandemic outbreak in 2020,” says a Fact.MR analyst.
For More Information On How To Improve Your Polysaccharide Hemostatic System Market Footprint, Request A Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=6435
Key Takeaways from Polysaccharide Hemostatic System Market Survey
- In terms of applications, orthopedic surgeries will dominate the segment, followed by cardiovascular surgeries.
- The U.S. polysaccharide hemostatic system market is anticipated to witness healthy growth through 2031, owing to wide adoption of technologically advanced medical systems.
- The U.K. polysaccharide hemostatic system market will grow at a steady pace, owing to research and development and new product launches in the country.
Growth Drivers:
- Research and development aimed at increasing product efficacy will lead to better sales prospects in polysaccharide hemostatic system market.
- Increasing adoption of technologically advanced medical devices will foster market sales in the upcoming years.
Ask Your Polysaccharide Hemostatic System Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6435
Competitive Landscape
Leading players in the polysaccharide hemostatic system market are investing in research and development to enhance their product portfolio. Additionally, gaining patents and approvals from regulatory bodies will remain a major growth strategy for the market players. For instance, in February 2021, EndoClot Plus Inc., received the approval from U.S. Food and drug Administration (FDA) for its polysaccharide hemostatic system. The PHS system is a starch-based powder hemostat that reliably controls gastrointestinal bleeding.
Key Manufacturers of Polysaccharide Hemostatic System Include:
- Starch Medical Inc.
- Medical Expo
- Medical Devices Business Services Inc.
- CryoLife Inc.
- EndoClot Plus Inc.
More Valuable Insights on Polysaccharide Hemostatic System Market
Fact MR provides an unbiased analysis of the polysaccharide hemostatic system market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global polysaccharide hemostatic system market with a detailed segmentation on the basis of:
Product:
- Polysaccharide Hemostatic System
Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Gynecological surgery
- Reconstructive surgery
- Cardiovascular surgery
End-User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Community healthcare
- Surgery Centers
- Nursing Homes
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Key Questions Covered in the Polysaccharide Hemostatic System Market Report
- The report offers insight into polysaccharide hemostatic system market demand outlook for 2021-2031
- The market study also highlights projected sales growth for polysaccharide hemostatic system market between 2021 and 2031
- Polysaccharide hemostatic system market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Polysaccharide hemostatic system market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain
Gastrointestinal Bleeding Treatment Market - Endoscopic hemostasis is gaining popularity as a treatment for gastrointestinal bleeding. Mechanical therapy, injection therapy, and thermal therapy are all well-established treatment modalities that have been used for years. That it can reduce the mortality associated with gastrointestinal bleeding is well known. To stop GI bleeding, leading technological developments in hemostatic sprays and stents are being used. The market for gastrointestinal bleeding treatment is expected to grow as a result of these developments.
Americas Hematology Diagnostics Market - The development of simple and painless blood testing systems has been made possible by technological advancements. It's also expected that the future of haematology diagnostics is affected by the increase in research and development of blood-related diseases. Over the forecast period, the market is expected to grow at a significant rate due to rising healthcare spending and attention.
Hemostasis Valves Market - The market growth is expected to be driven by the increasing preference for hemostasis valves among healthcare providers due to their efficiency in next-generation catheters and delivery systems, the increasing number of interventional procedures in various medical specialties, and the increasing number of coronary angiography procedures for the diagnosis of heart muscles. Between 2021 and 2031, the US Hemostasis Valve market is expected to follow a similar pattern to the past, with a boom and a bust.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR